Developer docs
API playgroundTry for free, no card

Search company profiles

Invetus

Full company profile

uuid000lc3g

Namestring
Invetus
Legal namestring
Invetus Proprietary Limited
Websiteurl
invetus.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Invetus is the largest Australian veterinary contract research organisation (CRO), operating three research facilities across Australia and New Zealand: Wongaburra Research Centre in Casino, NSW (companion animals); Armidale Research Centre in Armidale, NSW (production animals); and Estendart Research Centre in Palmerston North, NZ. The company was formed in December 2016 through the merger of Veterinary Health Research, Vetx Research (Australia), and Pharmfirst (NZ), bringing together decades of GLP-compliant animal health research capability. Invetus provides fee-for-service preclinical, clinical, efficacy, safety, residue, and bioequivalence studies to approximately 600 active customers across animal health companies, biotech firms, veterinarians, farmers, government bodies, and universities, with a staff of more than 70 (about one-third with university qualifications) and more than 500 years of combined veterinary and research experience.

The company's underlying technology is its integrated CRO platform: purpose-built facilities (climate-controlled housing for 120 dogs and 50 cats at WRC, plus full livestock/equine infrastructure at ARC), long-standing regulatory credentials (AAALAC accreditation—the first CRO in Australasia to achieve full AAALAC status in 2014—plus GLP, GCP, and GMP compliance), the Invetus Clinical Network (ICN) for multi-centre companion animal studies across 50+ veterinary hospitals, and the Invetus Pet Network for clinical trial recruitment. The business model is project-based contract research with quote-based pricing and multi-year contract cadences; revenue streams include contract research services, diagnostic/parasitology services, and a growing preclinical/ comparative oncology line serving human therapeutics developers. Notable capabilities include unique access to the paralysis tick (Ixodes holocyclus) endemic region in Northern Rivers NSW, contra-seasonal research advantages from Southern Hemisphere location, and comparative oncology using naturally occurring disease in companion animals as large mammal models for human drug development.

Short descriptiontext

Invetus is the largest Australian veterinary contract research organisation, providing preclinical, clinical, efficacy, safety and residue studies across companion and production animals from three research facilities in Australia and New Zealand for animal health companies, biotech firms, veterinarians, governments and universities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersArmidale, Australia
HQ citystring
Armidale
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary contract research, animal health research, clinical trial services, preclinical research services, pharmaceutical contract research
Industry2 codes
PRIMARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAMANAL
Clinical Research, Trials & Translational Services (Veterinary Regenerative)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals
NAICS code2 codes
  • Veterinary Services54194
  • Support Activities for Animal Production1152
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Engineering, Accounting, Research, Management8700
Product category
Veterinary Contract Research Services
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Contract Research Services
TypeProfessional Services
Description

Fee-for-service contract research for animal health companies developing veterinary products. Studies are designed to satisfy international, commonwealth and state registration requirements. Revenue generated through project-based contracts for efficacy, safety, residue, and clinical studies.

invetus.com
2Diagnostic Services
TypeProfessional Services
Description

Parasite monitoring and diagnostic services including faecal egg counts, worm monitoring, drench resistance testing for farmers and graziers. Offered both directly and via rural store distribution.

invetus.com
3Preclinical Research Services
TypeProfessional Services
Description

Preclinical trials in large mammal species including sheep, pigs and dogs for human therapeutics companies. Can assist in reducing cost and time to Phase 1 trials for human therapeutics.

invetus.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Custom research project pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing varies by project scope, species, study type, and regulatory requirements. Quote-based pricing. Sponsors have requested early warning of price changes for budgeting purposes.

invetus.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Invetus is a veterinary contract research organisation (CRO) that designs and conducts preclinical and clinical studies for animal health and human therapeutic products across companion and production animal species. The company operates three wholly-owned research facilities—Wongaburra Research Centre in Casino NSW (companion animals), Armidale Research Centre in NSW (production animals), and Estendart Research Centre in Palmerston North, New Zealand—supported by the Invetus Clinical Network for multi-centre companion animal trials and the Invetus Pet Network for clinical trial recruitment.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Net Promoter Score of 58
+2 more records
Product overview1 text field

Invetus is a veterinary contract research organisation (CRO) providing comprehensive animal health research services across Australia and New Zealand. The company operates through three main research facilities—Wongaburra Research Centre (companion animals) and Armidale Research Centre (production animals) in Australia, plus the Estendart Research Centre in New Zealand—supported by the Invetus Clinical Network for multi-centre companion animal field studies. Services span preclinical studies for human therapeutics, clinical trials, laboratory studies, and parasitology research. The company also operates the Invetus Pet Network for recruiting pet owners into clinical trials. Research capabilities include any species, any degree of rigour, and any area of animal health, covering both companion animals (dogs, cats) and production animals (cattle, sheep, horses, pigs, chickens, goats, alpacas, deer).

Product and service6 records
1Wongaburra Research Centre
CategoryResearch Facility — Companion Animals
Description

Main companion animal research facility located in Casino, Northern Rivers NSW, with climate-controlled individual housing for 120 dogs and 50 cats, a licensed veterinary hospital (Licence No. 000963), and veterinary entomology capabilities including access to paralysis tick (Ixodes holocyclus) endemic regions. Supports surgical, anaesthetic, efficacy and safety studies in companion animals for animal health sponsors.

2Armidale Research Centre
CategoryResearch Facility — Production Animals
Description

Main production animal research centre located at the University of New England campus in Armidale, NSW, offering pen and field study capabilities for cattle, sheep, horses, pigs, chickens, goats, alpacas, and deer. Hosts QA management, archiving, and most Finance and IT support for Invetus.

3Estendart Research Centre (ERC)
CategoryResearch Facility — New Zealand
Description

New Zealand research facility operating from Massey University campus in Palmerston North, plus the Jennersmead research farm at Bunnythorpe. Delivers veterinary and preclinical research services to GLP standards with GMP certified manufacturing capabilities for animal health sponsors operating in New Zealand.

4Invetus Clinical Network (ICN)
CategoryClinical Trial Service Network — Companion Animals
Description

Multi-centre clinical research network providing a single point of contact for companion animal clinical studies across eastern Australia, using trained investigators in GCP studies with experienced monitors ensuring quality from start to finish. VCRN has worked with over 50 veterinary hospitals and specialists in Australia.

5Invetus Pet Network
CategoryClinical Trial Recruitment Platform
Description

Platform partnering with veterinarians and pet owners to enroll dogs and cats in clinical trials evaluating new veterinary medicines, preventatives, and treatments. Provides opportunities for pet owners whose pets have specific diseases or conditions to participate in studies that develop new treatments.

6Preclinical Research Services
CategoryPreclinical Research — Human Therapeutics
Description

Preclinical trials in large mammal species including sheep, pigs, and dogs for human therapeutics companies. Comparative oncology uses spontaneously occurring cancers in companion animals to de-risk and reduce cost and time to Phase I trials for human drug development.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

R&D project grant of approximately $400,000 for sustainable worm control in free-range laying systems. Australian Eggs contributing $150,000 cash with remainder in-kind. Project includes PhD student supervision.

2CSIRO
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

Collaboration through ON Prime business development program focused on comparative oncology. CSIRO's Probing Biosystems unit working with Invetus on using spontaneous disease in companion animals as models for human disease. Team awarded $3,000 in competitive grants.

invetus.com
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

Partnership at BIO-Europe 2018 for overseas drug/device developers. Together offer one-stop-shop for R&D programs with Invetus providing large animal models and GreenLight providing full-service CRO services across all phases.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

Contract research partnership for registration trials of cannabis-based pain relief drugs for animals. Phase I research for CPAT-01 for pain and inflammation in dogs. CPAT-01 results presented at 2019 AVA symposium.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

Collaboration on antimicrobial stewardship and UTI management in dogs. Study comparing two antibiotics in urinary tract infections presented at ASAVA conference. Greencross also working with University of Melbourne on antimicrobial stewardship programs.

6Meat & Livestock Australia (MLA)
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2017-01-01
Description

One of 12 project partners in $9.2m dung beetle ecosystem engineering project. Invetus leads mass rearing, distribution and site monitoring to ensure establishment of new beetle species. Project includes CSIRO, universities and farmers.

invetus.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with University of New England for production animal research. ARC is located at UNE campus. Collaboration on R&D projects including Australian Eggs Limited funding for worm control research. Provides access to university expertise and rural infrastructure.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Estendart Research Centre operates on Massey University campus in Palmerston North, NZ. Animal research facilities have existed there for over 30 years with ongoing access to university expertise and facilities.

Strategic tierMinorTypeOthers
Description

Charitable partnership supporting Animal Management in Rural and Remote Indigenous Communities. Invetus chooses to support this not-for-profit charity using One Health approach.

Strategic tierMinorTypeOthers
Description

Donated to DELTA Society which provides pets as therapy for disabled, elderly and disadvantaged members of society.

Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global preclinical CRO with large-animal safety/efficacy and research models capabilities that overlap directly with Invetus's preclinical and animal-health research services. Far larger scale, but operates Invetus's same category of work across multiple species.

TypeDirect peer
Description

US-based contract research organisation focused on preclinical and animal-model research for pharma and medical-device clients. Highly comparable to Invetus's preclinical large-mammal and translational offerings, including comparative models.

TypeDirect peer
Description

Early-stage clinical and preclinical CRO that conducts first-in-human and translational studies, including work supported by large-animal models. Closely aligned with Invetus's preclinical-to-Phase-1 positioning for human therapeutics.

TypeBroad incumbent
Description

One of the world's largest CROs offering preclinical, clinical, and central-lab services across all therapeutic areas. Competes with Invetus for multi-regional sponsor mandates and sets pricing benchmarks for veterinary-adjacent preclinical work.

TypeBroad incumbent
Description

Global CRO providing outsourced development and commercialisation services to pharma and biotech. Overlaps with Invetus through clinical operations and is a competitor for any sponsor programme that requires Australian/NZ capacity.

TypeBroad incumbent
Description

International bioanalytical and contract laboratory group serving pharma, animal health, and agrochemical clients. Comparable to Invetus on the laboratory/regulatory-study side of veterinary contract research.

TypeBroad incumbent
Description

Global CRO/CDMO offering preclinical, clinical, and laboratory services. Competes for sponsor preclinical and translational work that Invetus also targets through its comparative-oncology and large-animal services.

TypeOthers
Description

Largest global animal-health company that runs significant in-house R&D and veterinary clinical research. Not a direct CRO peer but a primary customer for veterinary CRO services of the kind Invetus provides.

TypeOthers
Description

Global leader in veterinary diagnostics and reference laboratory services with companion-animal research collaborations. Adjacent rather than directly competitive but operates in the same veterinary evidence-generation ecosystem as Invetus.

TypeEmerging player
Description

Mid-sized CRO focused on adaptive clinical trial design and biopharma services, often partnering with specialty CROs for niche indications. A potential collaboration partner for Invetus on animal-health or comparative-oncology trials.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Invetus

Veterinary Contract Research Servicesinvetus.com

Invetus is the largest Australian veterinary contract research organisation, providing preclinical, clinical, efficacy, safety and residue studies across companion and production animals from three research facilities in Australia and New Zealand for animal health companies, biotech firms, veterinarians, governments and universities.

What Invetus does

Invetus is the largest Australian veterinary contract research organisation (CRO), operating three research facilities across Australia and New Zealand: Wongaburra Research Centre in Casino, NSW (companion animals); Armidale Research Centre in Armidale, NSW (production animals); and Estendart Research Centre in Palmerston North, NZ. The company was formed in December 2016 through the merger of Veterinary Health Research, Vetx Research (Australia), and Pharmfirst (NZ), bringing together decades of GLP-compliant animal health research capability. Invetus provides fee-for-service preclinical, clinical, efficacy, safety, residue, and bioequivalence studies to approximately 600 active customers across animal health companies, biotech firms, veterinarians, farmers, government bodies, and universities, with a staff of more than 70 (about one-third with university qualifications) and more than 500 years of combined veterinary and research experience.

The company's underlying technology is its integrated CRO platform: purpose-built facilities (climate-controlled housing for 120 dogs and 50 cats at WRC, plus full livestock/equine infrastructure at ARC), long-standing regulatory credentials (AAALAC accreditation—the first CRO in Australasia to achieve full AAALAC status in 2014—plus GLP, GCP, and GMP compliance), the Invetus Clinical Network (ICN) for multi-centre companion animal studies across 50+ veterinary hospitals, and the Invetus Pet Network for clinical trial recruitment. The business model is project-based contract research with quote-based pricing and multi-year contract cadences; revenue streams include contract research services, diagnostic/parasitology services, and a growing preclinical/ comparative oncology line serving human therapeutics developers. Notable capabilities include unique access to the paralysis tick (Ixodes holocyclus) endemic region in Northern Rivers NSW, contra-seasonal research advantages from Southern Hemisphere location, and comparative oncology using naturally occurring disease in companion animals as large mammal models for human drug development.

Invetus firmographics

Firmographics
Name
Invetus
Legal name
Invetus Proprietary Limited
Website
https://invetus.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Invetus is the largest Australian veterinary contract research organisation, providing preclinical, clinical, efficacy, safety and residue studies across companion and production animals from three research facilities in Australia and New Zealand for animal health companies, biotech firms, veterinarians, governments and universities.
Ownership category
akta.pro rank

Invetus industry classification

Industry
Product category
Veterinary Contract Research Services
NAICS
Veterinary Services (54194), Support Activities for Animal Production (1152)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Engineering, Accounting, Research, Management (8700)
akta.pro industry
PRIMARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAMANAL
Clinical Research, Trials & Translational Services (Veterinary Regenerative)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals

Keywords

  • Veterinary contract research
  • Animal health research
  • Clinical trial services
  • Preclinical research services
  • Pharmaceutical contract research

Where Invetus is headquartered

Location

Headquarters

HQ city
Armidale
HQ country
Australia
HQ region
Oceania

Offices3 records

Markets served

Invetus business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Contract Research Services: Fee-for-service contract research for animal health companies developing veterinary products. Studies are designed to satisfy international, commonwealth and state registration requirements. Revenue generated through project-based contracts for efficacy, safety, residue, and clinical studies.
  2. Diagnostic Services: Parasite monitoring and diagnostic services including faecal egg counts, worm monitoring, drench resistance testing for farmers and graziers. Offered both directly and via rural store distribution.
  3. Preclinical Research Services: Preclinical trials in large mammal species including sheep, pigs and dogs for human therapeutics companies. Can assist in reducing cost and time to Phase 1 trials for human therapeutics.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom research project pricing

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Invetus product offering

Product offering

Core offering

Invetus is a veterinary contract research organisation (CRO) that designs and conducts preclinical and clinical studies for animal health and human therapeutic products across companion and production animal species. The company operates three wholly-owned research facilities—Wongaburra Research Centre in Casino NSW (companion animals), Armidale Research Centre in NSW (production animals), and Estendart Research Centre in Palmerston North, New Zealand—supported by the Invetus Clinical Network for multi-centre companion animal trials and the Invetus Pet Network for clinical trial recruitment.

Product overview

Invetus is a veterinary contract research organisation (CRO) providing comprehensive animal health research services across Australia and New Zealand. The company operates through three main research facilities—Wongaburra Research Centre (companion animals) and Armidale Research Centre (production animals) in Australia, plus the Estendart Research Centre in New Zealand—supported by the Invetus Clinical Network for multi-centre companion animal field studies. Services span preclinical studies for human therapeutics, clinical trials, laboratory studies, and parasitology research. The company also operates the Invetus Pet Network for recruiting pet owners into clinical trials. Research capabilities include any species, any degree of rigour, and any area of animal health, covering both companion animals (dogs, cats) and production animals (cattle, sheep, horses, pigs, chickens, goats, alpacas, deer).

Differentiator

Problem solved

Functional benefit

Products and services

  • Wongaburra Research Centre Main companion animal research facility located in Casino, Northern Rivers NSW, with climate-controlled individual housing for 120 dogs and 50 cats, a licensed veterinary hospital (Licence No. 000963), and veterinary entomology capabilities including access to paralysis tick (Ixodes holocyclus) endemic regions. Supports surgical, anaesthetic, efficacy and safety studies in companion animals for animal health sponsors.
  • Armidale Research Centre Main production animal research centre located at the University of New England campus in Armidale, NSW, offering pen and field study capabilities for cattle, sheep, horses, pigs, chickens, goats, alpacas, and deer. Hosts QA management, archiving, and most Finance and IT support for Invetus.
  • Estendart Research Centre (ERC) New Zealand research facility operating from Massey University campus in Palmerston North, plus the Jennersmead research farm at Bunnythorpe. Delivers veterinary and preclinical research services to GLP standards with GMP certified manufacturing capabilities for animal health sponsors operating in New Zealand.
  • Invetus Clinical Network (ICN) Multi-centre clinical research network providing a single point of contact for companion animal clinical studies across eastern Australia, using trained investigators in GCP studies with experienced monitors ensuring quality from start to finish. VCRN has worked with over 50 veterinary hospitals and specialists in Australia.
  • Invetus Pet Network Platform partnering with veterinarians and pet owners to enroll dogs and cats in clinical trials evaluating new veterinary medicines, preventatives, and treatments. Provides opportunities for pet owners whose pets have specific diseases or conditions to participate in studies that develop new treatments.
  • Preclinical Research Services Preclinical trials in large mammal species including sheep, pigs, and dogs for human therapeutics companies. Comparative oncology uses spontaneously occurring cancers in companion animals to de-risk and reduce cost and time to Phase I trials for human drug development.

Quantifiable outcome

  • Net Promoter Score of 58
  • +2 more outcomes

Companies that use Invetus

Customer profile

Named customers5 records

Segments6 records

Ideal customer profiles3 records

Invetus technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Invetus partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered strategic, core and minor.

  • Australian Eggs LimitedstrategicStrategic or Co-development Partner · 1 January 2019R&D project grant of approximately $400,000 for sustainable worm control in free-range laying systems. Australian Eggs contributing $150,000 cash with remainder in-kind. Project includes PhD student supervision.
  • CSIROstrategicStrategic or Co-development Partner · 1 January 2018Collaboration through ON Prime business development program focused on comparative oncology. CSIRO's Probing Biosystems unit working with Invetus on using spontaneous disease in companion animals as models for human disease. Team awarded $3,000 in competitive grants.
  • GreenLight ClinicalstrategicStrategic or Co-development Partner · 1 January 2018Partnership at BIO-Europe 2018 for overseas drug/device developers. Together offer one-stop-shop for R&D programs with Invetus providing large animal models and GreenLight providing full-service CRO services across all phases.
  • CannPalcoreStrategic or Co-development Partner · 1 January 2018Contract research partnership for registration trials of cannabis-based pain relief drugs for animals. Phase I research for CPAT-01 for pain and inflammation in dogs. CPAT-01 results presented at 2019 AVA symposium.
  • GreencrossstrategicStrategic or Co-development Partner · 1 January 2018Collaboration on antimicrobial stewardship and UTI management in dogs. Study comparing two antibiotics in urinary tract infections presented at ASAVA conference. Greencross also working with University of Melbourne on antimicrobial stewardship programs.
  • Meat & Livestock Australia (MLA)strategicStrategic or Co-development Partner · 1 January 2017One of 12 project partners in $9.2m dung beetle ecosystem engineering project. Invetus leads mass rearing, distribution and site monitoring to ensure establishment of new beetle species. Project includes CSIRO, universities and farmers.
  • University of New England (UNE)coreStrategic or Co-development PartnerPartnership with University of New England for production animal research. ARC is located at UNE campus. Collaboration on R&D projects including Australian Eggs Limited funding for worm control research. Provides access to university expertise and rural infrastructure.
  • Massey UniversitycoreStrategic or Co-development PartnerEstendart Research Centre operates on Massey University campus in Palmerston North, NZ. Animal research facilities have existed there for over 30 years with ongoing access to university expertise and facilities.
  • AMRRICminorOthersCharitable partnership supporting Animal Management in Rural and Remote Indigenous Communities. Invetus chooses to support this not-for-profit charity using One Health approach.
  • DELTA SocietyminorOthersDonated to DELTA Society which provides pets as therapy for disabled, elderly and disadvantaged members of society.

Scale indicators7 records

Recent moves2 records

Expansion highlights5 records

Invetus competitors and assessment

Company assessment

Broad incumbents

  • Charles River Laboratories: Global preclinical CRO with large-animal safety/efficacy and research models capabilities that overlap directly with Invetus's preclinical and animal-health research services. Far larger scale, but operates Invetus's same category of work across multiple species.
  • Labcorp Drug Development (formerly Covance): One of the world's largest CROs offering preclinical, clinical, and central-lab services across all therapeutic areas. Competes with Invetus for multi-regional sponsor mandates and sets pricing benchmarks for veterinary-adjacent preclinical work.
  • ICON plc: Global CRO providing outsourced development and commercialisation services to pharma and biotech. Overlaps with Invetus through clinical operations and is a competitor for any sponsor programme that requires Australian/NZ capacity.
  • Eurofins Scientific: International bioanalytical and contract laboratory group serving pharma, animal health, and agrochemical clients. Comparable to Invetus on the laboratory/regulatory-study side of veterinary contract research.
  • WuXi AppTec: Global CRO/CDMO offering preclinical, clinical, and laboratory services. Competes for sponsor preclinical and translational work that Invetus also targets through its comparative-oncology and large-animal services.

Direct peers

  • Inotiv: US-based contract research organisation focused on preclinical and animal-model research for pharma and medical-device clients. Highly comparable to Invetus's preclinical large-mammal and translational offerings, including comparative models.
  • Celerion: Early-stage clinical and preclinical CRO that conducts first-in-human and translational studies, including work supported by large-animal models. Closely aligned with Invetus's preclinical-to-Phase-1 positioning for human therapeutics.

Others

  • Zoetis: Largest global animal-health company that runs significant in-house R&D and veterinary clinical research. Not a direct CRO peer but a primary customer for veterinary CRO services of the kind Invetus provides.
  • IDEXX Laboratories: Global leader in veterinary diagnostics and reference laboratory services with companion-animal research collaborations. Adjacent rather than directly competitive but operates in the same veterinary evidence-generation ecosystem as Invetus.

Emerging players

  • Clinipace Worldwide: Mid-sized CRO focused on adaptive clinical trial design and biopharma services, often partnering with specialty CROs for niche indications. A potential collaboration partner for Invetus on animal-health or comparative-oncology trials.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Invetus social profiles

Digital presence

Invetus compliance and trust

Trust signal

Compliance6 records

Invetus financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Invetus leadership team

Management profile

Number of profiles

Profiles12 records

Invetus subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Invetus funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Invetus M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Invetus

What does Invetus do?

Invetus is a veterinary contract research organisation (CRO) that designs and conducts preclinical and clinical studies for animal health and human therapeutic products across companion and production animal species. The company operates three wholly-owned research facilities—Wongaburra Research Centre in Casino NSW (companion animals), Armidale Research Centre in NSW (production animals), and Estendart Research Centre in Palmerston North, New Zealand—supported by the Invetus Clinical Network for multi-centre companion animal trials and the Invetus Pet Network for clinical trial recruitment.

Is Invetus a public or private company?

Invetus is a private company. It is classified as private equity controlled and is currently operating.

When was Invetus founded?

Invetus was founded in 2016. It employs 11 to 50 people.

Where is Invetus based?

Invetus is headquartered in Armidale, Australia, in the Oceania region.

How does Invetus make money?

Three revenue lines are on record. Contract Research Services are the primary driver. The others are diagnostic Services and preclinical Research Services.

Who are Invetus's main competitors?

Broad incumbents on record are Charles River Laboratories, Labcorp Drug Development (formerly Covance), ICON plc, Eurofins Scientific and WuXi AppTec. Direct peers are Inotiv and Celerion. Others are Zoetis and IDEXX Laboratories. Clinipace Worldwide is listed as an emerging player.

Does Invetus have an API?

No public API is recorded for Invetus.

What industry is Invetus in?

Invetus's product category is Veterinary Contract Research Services. Its primary akta.pro industry code is HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease), with a secondary code of HLAMANAL, Clinical Research, Trials & Translational Services (Veterinary Regenerative). Its NAICS code is 54194 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales